OPAL INC
10-Q, 1996-08-07
SPECIAL INDUSTRY MACHINERY, NEC
Previous: R F MANAGEMENT CORP, 10-Q, 1996-08-07
Next: MCDERMOTT J RAY SA, 10-Q, 1996-08-07





                       SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                              ---------------------

                                    FORM 10-Q

         (Mark One)
         |X| QUARTERLY REPORT PURSUANT TO SECTION 13  OR 15(d) OF THE SECURITIES
             EXCHANGE ACT OF 1934

             FOR THE QUARTERLY PERIOD ENDED JUNE 30, 1996.

         [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
             EXCHANGE ACT OF 1934

             FOR THE TRANSITION PERIOD FROM ________ TO ________.

         Commission File Number:    0-25922


                                   Opal, Inc.
             (Exact name of registrant as specified in its charter)


           Delaware                                            04-2962212
(State or other jurisdiction of                               (IRS Employer
incorporation or organization)                             Identification No.)


               3203 Scott Boulevard, Santa Clara, California 95054
                    (Address of principal executive offices)

       Registrant's telephone number, including area code: (408) 727-6060

                             ---------------------

         Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months (or for such a shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.
         YES |X|  NO |_|

         The number of shares of  Registrant's  Common  Stock,  $0.01 par value,
outstanding as of August 5, 1996 was 8,715,298.



<PAGE>
                                   Opal, Inc.

                                      INDEX


                                                                        Page No.
                                                                        --------

Part 1.      Condensed Consolidated Financial Information

         Item 1.   Condensed Consolidated Financial Statements:

                   Condensed Consolidated Balance Sheets -
                      June 30, 1996 and December 31, 1995                     3

                   Condensed Consolidated Statements of Operations -
                      Three and six months ended June 30, 1996 and 1995       4

                   Condensed Consolidated Statements of Cash Flows -
                      Six months ended June 30, 1996 and 1995                 5

                   Notes to Condensed Consolidated Financial Statements       6

         Item 2.   Management's Discussion and Analysis of Financial
                      Condition and Results of Operations                     7


Part II.     Other Information

         Item 1-3.  Not applicable

         Item 4.    Submission of Matters to a Vote of Security Holders       10

         Item 5.    Not Applicable

         Item 6.    Exhibits and Reports on Form 8-K                          11


SIGNATURE                                                                     12


                    Exhibit 11.1 Computation of Net Income Per Common Share   13

                                       2

<PAGE>


                          PART 1. FINANCIAL INFORMATION


Item 1.  Condensed Consolidated Financial Statements

<TABLE>

                                                         OPAL, INC.

                                            CONDENSED CONSOLIDATED BALANCE SHEETS
                                     (in thousands, except share and per share amounts)
                                                         (unaudited)
<CAPTION>

                                                                                                     June 30,        December 31,
ASSETS                                                                                                 1996              1995
- - ------                                                                                                 ----              ----
<S>                                                                                             <C>             <C>            
Current assets:
     Cash and cash equivalents                                                                  $       20,145  $        12,562
     Short-term investments                                                                             14,447           14,473
     Accounts receivable, net                                                                            9,290           12,269
     Receivables - Government of Israel                                                                  1,695            1,188
     Inventories                                                                                        13,354           10,002
     Prepaid expenses and other assets                                                                     560              542
                                                                                                --------------  ---------------
           Total current assets                                                                         59,491           51,036
Property and equipment, net                                                                              4,186            4,216
                                                                                                --------------  ---------------
                                                                                                $       63,677  $        55,252
                                                                                                ==============  ===============
LIABILITIES AND STOCKHOLDERS' EQUITY
- - ------------------------------------
Current liabilities:
     Short-term bank loans                                                                      $           95  $           120
     Accounts payable                                                                                    2,345            2,487
     Accrued expenses and other liabilities                                                              8,301            6,137
                                                                                                --------------  ---------------
           Total current liabilities                                                                    10,741            8,744
                                                                                                --------------  ---------------

Stockholders' equity:
     Common Stock, par value $0.01 per share, 12,500,000 shares
        authorized; 8,715,298 and 8,687,587 shares issued and outstanding                                   87               87
     Capital in excess of par value                                                                     45,778           45,508
     Retained earnings                                                                                   7,305            1,221
     Deferred compensation expense                                                                        (209)            (283)
     Notes receivable from stockholders                                                                    (25)             (25)
                                                                                                --------------  ---------------
           Total stockholders' equity                                                                   52,936           46,508
                                                                                                --------------  ---------------
                                                                                                $       63,677  $        55,252
                                                                                                ==============  ===============

<FN>

                             See accompanying notes to condensed consolidated financial statements.

</FN>
</TABLE>

                                        3

<PAGE>
<TABLE>


                                                         OPAL, INC.

                                       CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                          (in thousands, except per share amounts)
                                                         (unaudited)
<CAPTION>

                                                                           Three months ended                Six months ended
                                                                                June 30,                         June 30,
                                                                       ----------------------------    -----------------------------
                                                                           1996           1995            1996             1995
                                                                           ----           ----            ----             ----

<S>                                                                      <C>           <C>              <C>             <C>       
Revenue                                                                  $  16,052     $   10,024       $  31,543       $   18,337
Cost of revenues                                                             7,564          4,664          14,822            8,553
                                                                         ---------     ----------       ---------       -----------
Gross profit                                                                 8,488          5,360          16,721            9,784
                                                                         ---------     ----------       ---------       -----------


Operating expenses:
         Research and development expenses                                   2,682          1,749           5,234            3,213
         Less:  grants                                                      (1,031)          (584)         (1,874)          (1,219)
                                                                         ---------     ----------       ---------       -----------

         Research and development, net                                       1,651          1,165           3,360            1,994
         Selling, general and administrative                                 3,736          2,294           7,246            4,258
                                                                         ---------     ----------       ---------       -----------

Income from operations                                                       3,101          1,901           6,115            3,532

Other income, net                                                              307            142             509              116
                                                                         ---------     ----------       ---------       -----------

Income before provision for income taxes                                     3,408          2,043           6,624            3,648
Provision for income taxes                                                     283             38             540               63
                                                                         ---------     ----------       ---------       -----------

Net income                                                               $   3,125     $    2,005       $   6,084       $    3,585
                                                                         =========     ==========       =========       ===========
Net income per share                                                     $    0.34     $     0.26       $    0.67       $     0.50
                                                                         =========     ==========       =========       ===========
Weighted average common shares and equivalents                               9,069          7,809           9,053            7,213
                                                                         =========     ==========       =========       ===========
<FN>
                               See accompanying notes to condensed consolidated financial statements.
</FN>
</TABLE>
                                        4
<PAGE>

<TABLE>

                                                         OPAL, INC.

                                       CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                      Increase (Decrease) in Cash and Cash Equivalents
                                                       (in thousands)
                                                         (unaudited)
<CAPTION>

                                                                                                       Six months ended
                                                                                                            June 30,
                                                                                                            --------
                                                                                                       1996           1995
                                                                                                       ----           -----
<S>                                                                                            <C>              <C>            
Cash flows from operating activities:
     Net income                                                                                $         6,084  $         3,585
     Adjustments to reconcile net income to net cash used in
       (provided by) operating activities:
           Depreciation, amortization and other                                                            692              431
           Changes in assets and liabilities:
                Accounts receivable                                                                      2,472           (3,842)
                Inventories                                                                             (3,352)          (1,430)
                Other current assets                                                                       (18)              96
                Accounts payable and accrued liabilities                                                 2,021            2,310
                                                                                                --------------  ---------------

Net cash provided by operating activities                                                                7,899            1,150
                                                                                                --------------  ---------------

Cash flows from investing activities:
     Investments in property and equipment                                                                (587)            (837)
     Purchase (Sale) of short-term investments available for sale                                           26           (4,850)
                                                                                                --------------  ---------------

Net cash provided by investing activities                                                                 (561)          (5,687)
                                                                                                --------------  ---------------

Cash flows from financing activities:
     Repayment of borrowings, net                                                                          (25)            (362)
     Repayment of Series E Mandatorily Redeemable Preferred Stock                                            -           (1,499)
     Proceeds from sale of stock, net of issuance costs                                                    270           27,644
                                                                                                --------------  ---------------

Net cash provided by investing activities                                                                  245           25,783
                                                                                                --------------  ---------------

Increase in cash and cash equivalents                                                                    7,583           21,246

Cash and cash equivalents at beginning of period                                                        12,562            1,398
                                                                                                --------------  ---------------

Cash and cash equivalents at end of period                                                      $       20,145  $        22,644
                                                                                                ==============  ===============

Supplemental disclosure of cash flow information:
     Cash paid for interest                                                                     $           25  $            77
     Cash paid for income taxes                                                                 $          143  $             -

<FN>
                               See accompanying notes to condensed consolidated financial statements.
</FN>
</TABLE>
                                        5

<PAGE>


                                   OPAL, INC.

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                   (unaudited)


1.       The  unaudited  financial  information  furnished  herein  reflects all
         adjustments,  consisting only of normal recurring adjustments,  that in
         the opinion of  management  are necessary to fairly state the Company's
         and its subsidiary's  consolidated  financial position,  the results of
         their operations,  and their cash flows for the periods presented. This
         Quarterly  Report on Form 10-Q should be read in  conjunction  with the
         Company's audited  consolidated  financial statements and notes thereto
         for the year ended  December 31, 1995,  included in the Company's  1995
         Annual  Report and Form 10K. The condensed  consolidated  statements of
         operations  for the six months ended June 30, 1996 are not  necessarily
         indicative  of  results  to be  expected  for the  entire  year  ending
         December 31, 1996.

2.       The  preparation  of these interim  condensed  financial  statements in
         conformity  with  generally  accepted  accounting  principles  requires
         management to make estimates and  assumptions  that affect the reported
         amounts of assets and liabilities  and disclosure of contingent  assets
         and  liabilities  at the  date  of the  financial  statements  and  the
         reported amounts of revenues and expenses during the reporting  period.
         Actual results could differ from those estimates.

                                       6
<PAGE>


                                   OPAL, INC.

Item 2.  Management's Discussion and Analysis of Financial Condition and Results
         of Operations


Results of Operations
- - ---------------------

Revenue

Revenues increased 60% to $16.1 million for the quarter ended June 30, 1996 from
$10.0  million for the quarter  ended June 30, 1995 and  increased  72% to $31.5
million for the six months  ended June 30,  1996 from $18.3  million for the six
months ended June 30, 1995 due to  increased  unit sales and due to the majority
of sales in 1996 being of the more  advanced and higher priced Opal 7830i CD-SEM
system  versus the majority of sales in the first two quarters of 1995 being the
Opal 7830 CD-SEM system. Additionally, sales in the first and second quarters of
1996 were favorably  impacted by the introduction and inclusion of a workstation
with the Opal  7830i.  Sales  outside of the U.S.  accounted  for 25% and 19% of
total net sales for the second quarter of 1996 and 1995, respectively.

Gross margins

Gross  margins for the quarter and six months ended June 30, 1996 were 52.9% and
53.0%,  respectively,  as  compared  to 53.5% and 53.4% for the  quarter and six
months ended June 30, 1995,  respectively.  The  decrease was  primarily  due to
higher material costs which the company was not able to pass on to customers.

Research and development, net

Research and  development,  net,  increased  42% to $1.7 million for the quarter
ended June 30, 1996 from $1.2  million  for the quarter  ended June 30, 1995 and
increased  69% to $3.4  million for the six months ended June 30, 1996 from $2.0
million for the six months ended June 30, 1995.  Gross research and  development
expenses  increased by 53% to $2.7  million for the quarter  ended June 30, 1996
from $1.7 million for the quarter ended June 30, 1995, and increased 63% to $5.2
million  for the six months  ended June 30,  1996 from $3.2  million for the six
months ended June 30, 1995. Grants from the Office of the Chief Scientist in the
Israeli Ministry of Industry and Trade (the "Chief Scientist") increased to $1.0
million for the quarter  ended June 30, 1996 from $584,000 for the quarter ended
June 30, 1995 and  increased  54% to $1.9  million for the six months ended June
30, 1996 from $1.2 million for the six months ended June 30, 1995.  Research and
development, net, as a percentage of revenue decreased to 10% of revenue for the
quarter  ended June 30, 1996 from 12% of revenue for the quarter  ended June 30,
1995;  for the six months  ended June 30, 1996 and 1995 it remained  constant at
11%.  Increased  research  and  development  expenses  in  absolute  terms  were
primarily directed at enhancing the new Opal 7830i and developing new products.

The Company  conducts  all of its  research and  development  activities  at its
facility in Israel.  Grants from the Chief Scientist are accounted for using the
cost  reduction  method,  under which  research  and  development  expenses  are
decreased  by the amounts of the grants.  The Company is not  obligated to repay
these  grants;  however,  it is required  to pay a royalty  based on the sale of
products utilizing the technology that was partially funded by grant proceeds.

The  Company  intends to  continue  significant  expenditures  on  research  and
development to develop new products and enhance its existing products. While the
Company believes that these current research and development  expenditures 

                                       7
<PAGE>

will be beneficial in the long term development of its business, there can be no
assurance  that the Company's  development  and  enhancement of products will be
successful.  Research and development expenditures are incurred substantially in
advance of related  revenue and in some cases do not result in the generation of
revenue.


Selling, general and administrative

Selling,  general and  administrative  expenses increased by 63% to $3.7 million
for the quarter ended June 30, 1996 from $2.3 million for the quarter ended June
30, 1995 and  increased by 70% to $7.2 million for the six months ended June 30,
1996 from $4.3 million for the six months ended June 30, 1995.  The increase was
primarily driven by increased  headcount and higher sales commissions related to
increased  revenues.  On a percentage  of revenue  basis,  selling,  general and
administrative  expenses remained constant at 23% for the quarter and six months
ended June 30,  1996,  respectively,  as compared to 23% for the same periods in
the prior year.


Other income (expense), net

Other income  (expense),  net,  which  consists  primarily  of interest  income,
interest expense and foreign  exchange gains (losses),  amounted to $307,000 for
the quarter ended June 30, 1996 and $509,000 for the six month period ended June
30, 1996 as compared to $142,000  and  $116,000  for the  comparable  periods in
1995.  The increase is primarily due to interest  income earned on proceeds from
the Company's initial public offering in May 1995.


Income tax provision

The effective tax rate for the six months ended June 30, 1996 was 8% and differs
from statutory tax rates  principally  because of the benefits of an Israeli tax
holiday.


Non-U.S. costs

A  significant  portion of the  Company's  expenses  are  incurred in Israel and
accordingly  are  non-U.S.  dollar  denominated.  Consequently,  the  Company is
exposed to fluctuations in shekel exchange rates.  Such  fluctuations  can cause
the Company's Israeli operating  expenses which are translated into U.S. dollars
for financial statement reporting purposes to vary from period to period.

The Company's cash flows are substantially U.S. dollar denominated. However, the
Company is  exposed to certain  foreign  currency  fluctuations,  primarily  the
Israeli  shekel and German  Mark.  To hedge  against  these  currency  exposures
incurred in the  ordinary  course of business,  the Company  enters into foreign
currency  forward  contracts  for amounts  consistent  with its vendor  purchase
commitments.  Gains and losses on these foreign currency  contracts are deferred
and offset by gains and losses on the underlying hedged transactions. As of June
30, 1996, deferred gains and losses from hedging transactions were not material.

The  counterparties  to  these  contracts  consist  of  international  financial
institutions. By policy, the Company monitors the credit ratings and capital and
surplus  of  its   counterparties.   Although  the  Company  attempts  to  hedge
significant foreign currency exposures,  no assurance can be given that exchange
rate movements will not have a material adverse impact on the Company's  results
of operations.  At June 30, 1996, the Company had outstanding  foreign

                                       8
<PAGE>

currency  forward  contracts  aggregating   approximately  $1.8  million.  These
contracts  mature at various  periods  through 1996 and are consistent  with the
amounts and timing of the underlying purchase commitments.


Factors affecting future operating results

The  Company's  future  results  will  depend  on its  ability  to  continuously
introduce new products and enhancements to existing products as customer demands
for higher  productivity and  specifications  of  semiconductor  process control
equipment  change or increase.  The  Company's  results could be affected by the
ability of competitors to introduce new products that have technological  and/or
price advantages.  Additionally,  the Company's  operating results may fluctuate
due to a variety of factors,  including  the  cyclicality  of the  semiconductor
industry,  the timing of orders, order cancellations and shipment  rescheduling.
In this regard, although the Company has not experienced a decline in unit sales
to  date,  no  assurance  can be given  that  semiconductor  manufacturers  will
continue to expand fabrication facilities or build new fabrication facilities at
a rate which will  assure an increase  in demand for the  Company's  products or
that the  current  rate of unit sales will not  decline  especially  in light of
uncertain short-term market conditions and heightened competition.


Liquidity and Capital Resources

Cash, cash equivalents and short-term  investments increased to $34.6 million at
June 30, 1996 from $27.0 million at December 31, 1995. The increase is primarily
attributable  to the generation of $7.9 million in cash from  operations.  As of
June 30, 1996, the Company had no material commitments for capital expenditures.

Assuming there is no significant change in the Company's  business,  the Company
believes that the existing cash and short-term investment balances and cash flow
from operations will be sufficient to meet its working capital  requirements for
at least the next twelve months. The statement made in the preceding sentence is
a forward-looking  statement, and as such is subject to a number of risk factors
that  could  cause the  Company's  actual  results to differ  materially.  These
factors  include  the risk that price  reductions  or declines in demand for the
Company's  systems,   which  constitute  a  single  product  line,  will  occur;
competition  from larger  public  companies in the  semiconductor  manufacturing
capital equipment industry; dependence on single or limited source suppliers for
certain  proprietary  components  which are  essential to the  technology of the
Company's  products;  cyclicality in the semiconductor  industry,  which affects
demand for the  Company's  products;  the rapidity of  technological  change and
highly competitive nature of the semiconductor  manufacturing  capital equipment
industry;  regulatory,  political,  economic and currency risks  associated with
international  sales;  and growth and expansion of the Company's  operations and
resultant  strain on its limited  personnel and  management,  manufacturing  and
other resources.

                                       9
<PAGE>


                           PART II. OTHER INFORMATION


                                   OPAL, INC.

Item 1-3.          Not applicable



Item 4.            Submission of Matters to a Vote of Security-Holders
<TABLE>

         The  Company's  first  Annual  Meeting  of  Stockholders  (the  "Annual
Meeting")  was  held on  April  29,  1996 for the  following  purposes:  (1) The
election of Uzia Galil, Dan Maydan and Israel Niv as the three Class I Directors
of the Company to hold office until the Annual Meeting of  Stockholders  in 1999
and until their  successors are duly elected and qualified;  (2) the approval of
an amendment to the Company's  Employee Stock Option Plan to increase the number
of shares of the  Company's  Common  Stock  that may be issued  thereunder  from
827,157  to  1,200,000;  and (3) the  ratification  of the  selection  of  Price
Waterhouse  LLP as the  independent  accountants  of the Company for the current
fiscal year. The following table describes the results of the shareholder votes.

<CAPTION>

                                                                             Votes in Favor            Votes Withheld
                                                                             --------------            --------------
<S>                                                                              <C>                        <C>   
Election of Uzia Galil as a Class I Director                                     7,922,280                  14,930

Election of Dan Maydan as a Class I Director                                     7,922,280                  14,930

Election of Israel Niv as a Class I Director                                     7,922,280                  14,930


                                                              Votes in         Votes                         Broker
                                                               Favor          Opposed         Abstain       Nonvotes
                                                              --------        -------         -------       --------
Approval of Amendment to the
     Company's Employee Stock Option Plan                     7,567,707        93,945          9,980         266,178

Ratification of Selection of Independent
     Accountants                                              7,886,684        15,230         35,926              --

</TABLE>



Item 5.            Not applicable

                                       10

<PAGE>



Item 6.            Exhibits and Reports on Form 8-K

                     a)   Exhibits

                          11.1   Computation of Net Income Per Common Share 
                                 (filed herewith)

                          27     Financial Data Schedule

                     b)   Reports on Form 8-K

                          No  reports  on Form 8-K were  filed  during the three
                          months ended June 30, 1996.



                                       11


<PAGE>





                                    SIGNATURE




Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.


Date:      August 5, 1996                   OPAL, INC.
                                           (Registrant)



                                         /s/ Henry Schwarzbaum
                                ------------------------------------------------
                                Henry Schwarzbaum
                                Vice President of Finance
                                Chief Financial Officer and Secretary
                                (Duly Authorized Officer and Principal Financial
                                    and Accounting Officer)

                                       12



<TABLE>

Exhibit 11.1

                                                         OPAL, INC.


                                            COMPUTATION OF NET INCOME PER COMMON
                                                 AND COMMON EQUIVALENT SHARE

                                           (in thousands, except per share amounts)
                                                         (unaudited)
<CAPTION>

                                                                            Three months ended                Six months ended
                                                                                 June 30,                         June 30,
                                                                       -----------------------------    ----------------------------
                                                                           1996            1995           1996             1995
                                                                           ----            ----           ----             ----

<S>                                                                      <C>             <C>         <C>               <C>  
Weighted average common shares outstanding                                    8,688           7,413          8,688           6,839
Weighted average common equivalent shares from dilutive
     options (1)                                                                381             185            365             271
Weighted average common equivalent shares from dilutive options other
     than options included under footnote (1)                                     -             211              -             103
                                                                       ------------    ------------   ------------    -------------

Weighted average common shares and equivalents                                9,069           7,809          9,053           7,213
                                                                       ============    ============   ============    =============
Net income                                                               $    3,125      $    2,005    $     6,084     $     3,585
                                                                       ============    ============   ============    =============
Net income per share                                                     $     0.34      $     0.26    $      0.67     $      0.50
                                                                       ============    ============   ============    =============
<FN>

(1)     Pursuant to the requirements of the Securities and Exchange  Commission,
        common  equivalent  shares relating to stock options (using the treasury
        stock method and the initial public  offering price of $13.00 per share)
        issued during the 12-month  period prior to the initial public  offering
        are included in the  computation  for the three and six month ended June
        30, 1995 through to May 18, 1995.

</FN>
</TABLE>

                                       13

<TABLE> <S> <C>


<ARTICLE>                     5

       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                              DEC-31-1995
<PERIOD-START>                                 APR-01-1996
<PERIOD-END>                                   JUN-30-1996
<CASH>                                         20,145,000
<SECURITIES>                                   14,447,000
<RECEIVABLES>                                  11,515,000
<ALLOWANCES>                                      530,000
<INVENTORY>                                    13,354,000
<CURRENT-ASSETS>                               59,491,000
<PP&E>                                          7,318,000
<DEPRECIATION>                                  3,132,000
<TOTAL-ASSETS>                                 63,677,000
<CURRENT-LIABILITIES>                          10,741,000
<BONDS>                                                 0
<COMMON>                                           87,000
                                   0
                                             0
<OTHER-SE>                                     52,849,000
<TOTAL-LIABILITY-AND-EQUITY>                   63,677,000
<SALES>                                        16,052,000
<TOTAL-REVENUES>                               16,052,000
<CGS>                                           7,564,000
<TOTAL-COSTS>                                   7,564,000
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                 26,000
<INCOME-PRETAX>                                 3,408,000
<INCOME-TAX>                                      283,000
<INCOME-CONTINUING>                             3,125,000
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                    3,125,000
<EPS-PRIMARY>                                        0.34
<EPS-DILUTED>                                        0.34
        


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission